FDA-cleared NGS assay with the largest panel of clinically relevant, functionally validated cystic fibrosis variants in a diverse population.
FDA-cleared next-generation sequencing assay provides a full view of coding regions of the CFTR gene, to aid in in vitro diagnosis of cystic fibrosis.
A validated, FDA-regulated and CE-IVD-marked kit enabling clinical laboratories to design their own next-generation sequencing assays for use on the MiSeqDx and NextSeq 550Dx systems.
Illumina services and support begins when the MiSeqDx System is delivered. Illumina scientists and engineers assist with NGS system installation and setup and train laboratory personnel. In addition to on-site support, training courses are available to bring laboratory personnel quickly up to speed.
Illumina scientists are available 24/7 globally to answer questions every step of the way, enabling researchers to focus on making the next breakthrough discovery.
We offer comprehensive qualification services to help labs meet compliance requirements.
Get high-quality results on Illumina technology even faster with instructor-led, hands-on courses and web-based training options.
Illumina provides consulting services that connect an experienced Illumina team direct to the laboratory to jump-start successful sequencing workflow implementation.